Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

BST2 is a key marker for hair loss disease alopecia areata.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Early biotin treatment can reverse symptoms of congenital biotinidase deficiency.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

BMP-2 activates the Dlx3 gene in mouse skin cells, important for hair and skin development.

Improper use of benzyl benzoate on a dog can cause severe skin reactions.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

Snail2 is crucial for hair growth and affects skin cancer development.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Individualized treatments may help manage Dercum's disease symptoms.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Somatic BHD mutations are rare in Japanese renal tumors.

Baricitinib was effective in treating both early and late onset alopecia areata.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.